{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:44:35Z","timestamp":1793241875219,"version":"4.5.0"},"reference-count":93,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Congenital factor VII (FVII) deficiency, the most frequent among the recessively inherited disorders of blood coagulation, is characterized by a wide range of symptoms, from mild mucosal bleeds to life-threatening intracranial hemorrhage. Complete FVII deficiency may cause perinatal lethality. Clinically relevant thresholds of plasma levels are still uncertain, and modest differences in low FVII levels are associated with large differences in clinical phenotypes. Activated FVII (FVIIa) expresses its physiological protease activity only in a complex with tissue factor (TF), which triggers clotting at a very low concentration. Knowledge of the FVIIa\u2013TF complex helps to interpret the clinical findings associated with low FVII activity as compared with other rare bleeding disorders and permits effective management, including prophylaxis, with recombinant FVIIa, which, however, displays a short half-life. Newly devised substitutive and nonsubstitutive treatments, characterized by extended half-life properties, may further improve the quality of life of patients. Genetic diagnosis has been performed in thousands of patients with FVII deficiency, and among the heterogeneous F7 mutations, mostly missense changes, several recurrent variants show geographical distribution and identity by descent. In the general population, common F7 polymorphisms explain a large proportion of FVII level variance in plasma through FVII-lowering effects. Their combination with pathogenic variants may impact on the frequent detection of FVII coagulant levels lower than normal, as well as on mild bleeding conditions. In the twenties of this century, 70 years after the first report of FVII deficiency, more than 200 studies\/reports about FVII\/FVII deficiency have been published, with thousands of FVII-deficient patients characterized all over the world.<\/jats:p>","DOI":"10.1055\/s-0044-1788792","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T23:22:41Z","timestamp":1724973761000},"page":"128-137","source":"Crossref","is-referenced-by-count":11,"title":["Clinical, Laboratory, and Molecular Aspects of Factor VII Deficiency"],"prefix":"10.1055","volume":"51","author":[{"given":"Francesco","family":"Bernardi","sequence":"additional","affiliation":[{"name":"Department of Life Science and Biotechnology, University of Ferrara, Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guglielmo","family":"Mariani","sequence":"additional","affiliation":[{"name":"Independent Scientist, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"issue":"06","key":"ref1","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1172\/JCI102477","article-title":"Congenital SPCA deficiency: a hitherto unrecognized coagulation defect with hemorrhage rectified by serum and serum fractions","volume":"30","author":"B Alexander","year":"1951","journal-title":"J Clin Invest"},{"key":"ref3","first-page":"54","article-title":"National Registry of congenital bleeding disorders (AICE). Report 2017. Istituto Superiore di Sanit\u00e0","volume":"III","author":"F Abbonizio","year":"2019","journal-title":"Rapp ISTISAN"},{"issue":"13","key":"ref4","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1182\/blood-2014-08-532820","article-title":"Rare bleeding disorders: diagnosis and treatment","volume":"125","author":"R Palla","year":"2015","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"101029","DOI":"10.1016\/j.blre.2022.101029","article-title":"Molecular basis of rare congenital bleeding disorders","volume":"59","author":"A Dorgalaleh","year":"2023","journal-title":"Blood Rev"},{"issue":"02","key":"ref6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jha2.664","article-title":"VHrare study: prevalence, clinical features and management of severe rare bleeding disorders in a large cohort","volume":"4","author":"O Ben\u00edtez Hidalgo","year":"2023","journal-title":"eJHaem"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/(SICI)1098-1004(1996)8:2<108::AID-HUMU2>3.0.CO;2-7","article-title":"Mutation pattern in clinically asymptomatic coagulation factor VII deficiency","volume":"8","author":"F Bernardi","year":"1996","journal-title":"Hum Mutat"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1098-1004(2001)17:1<3::AID-HUMU2>3.0.CO;2-V","article-title":"Factor VII deficiency and the FVII mutation database","volume":"17","author":"J H McVey","year":"2001","journal-title":"Hum Mutat"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1076029621996813","DOI":"10.1177\/1076029621996813","article-title":"Congenital combined bleeding disorders, a comprehensive study of a large number of Iranian patients","volume":"27","author":"S E Ahmadi","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"issue":"01","key":"ref10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/jcm13010049","article-title":"Genotype-phenotype relationship among 785 unrelated white women with inherited congenital factor VII deficiency: a three-center database study","volume":"13","author":"S Halimeh","year":"2023","journal-title":"J Clin Med"},{"issue":"05","key":"ref11","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1538-7836.2009.03329.x","article-title":"Major differences in bleeding symptoms between factor VII deficiency and hemophilia B","volume":"7","author":"F Bernardi","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref12","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1160\/TH12-10-0740","article-title":"Bleeding symptoms at disease presentation and prediction of ensuing bleeding in inherited FVII deficiency","volume":"109","author":"M ND Di Minno","year":"2013","journal-title":"Thromb Haemost"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.thromres.2016.11.008","article-title":"Establishment of a bleeding score as a diagnostic tool for patients with rare bleeding disorders","volume":"148","author":"R Palla","year":"2016","journal-title":"Thromb Res"},{"issue":"20","key":"ref14","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1182\/bloodadvances.2020002740","article-title":"Bleeding severity in patients with rare bleeding disorders: real-life data from the RBiN study","volume":"4","author":"J L Saes","year":"2020","journal-title":"Blood Adv"},{"issue":"06","key":"ref15","doi-asserted-by":"crossref","first-page":"e527","DOI":"10.1097\/MPH.0000000000001564","article-title":"Evaluation of bleeding phenotype of inherited factor VII deficiency in children with a bleeding assessment tool and global assays","volume":"42","author":"E Toret","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"issue":"03","key":"ref16","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1160\/TH04-10-0650","article-title":"Clinical phenotypes and factor VII genotype in congenital factor VII deficiency","volume":"93","author":"G Mariani","year":"2005","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref17","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1182\/blood.V92.3.920","article-title":"Exclusion of the first EGF domain of factor VII by a splice site mutation causes lethal factor VII deficiency","volume":"92","author":"J H McVey","year":"1998","journal-title":"Blood"},{"issue":"S 01","key":"ref18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1538-7836.2011.04372.x","article-title":"Gynecological and obstetrical manifestations of inherited bleeding disorders in women","volume":"9","author":"F Peyvandi","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1111\/jth.15872","article-title":"Reproductive health and hemostatic issues in women and girls with congenital factor VII deficiency: a systematic review","volume":"20","author":"R Abdul-Kadir","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"05","key":"ref20","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/hae.12978","article-title":"Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies","volume":"22","author":"M Napolitano","year":"2016","journal-title":"Haemophilia"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1111\/jth.15801","article-title":"Extracellular vesicles from amniotic fluid, milk, saliva, and urine expose complexes of tissue factor and activated factor VII","volume":"20","author":"Y Hu","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2516.2008.01910.x","article-title":"Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene","volume":"15","author":"F H Herrmann","year":"2009","journal-title":"Haemophilia"},{"issue":"06","key":"ref23","first-page":"340","article-title":"A retrospective analysis of 157 surgical procedures performed without replacement therapy in 83 unrelated factor VII-deficient patients","volume":"152","author":"F Benlakhl","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"07","key":"ref24","doi-asserted-by":"crossref","first-page":"102199","DOI":"10.1016\/j.rpth.2023.102199","article-title":"Surgery in rare bleeding disorders: the prospective MARACHI study","volume":"7","author":"F Rousseau","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"06","key":"ref25","first-page":"704","article-title":"Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk?","volume":"89","author":"M Giansily-Blaizot","year":"2004","journal-title":"Haematologica"},{"issue":"06","key":"ref26","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/hae.12702","article-title":"Long-term prophylaxis in severe factor VII deficiency","volume":"21","author":"S M Siboni","year":"2015","journal-title":"Haemophilia"},{"issue":"03","key":"ref27","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1365-2141.2010.08287.x","article-title":"Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation - the surgical STER","volume":"152","author":"G Mariani","year":"2011","journal-title":"Br J Haematol"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1182\/blood-2003-04-1199","article-title":"Coinheritance of factor V (FV) Leiden enhances thrombin formation and is associated with a mild bleeding phenotype in patients homozygous for the FVII 9726+5G>A (FVII Lazio) mutation","volume":"102","author":"E Castoldi","year":"2003","journal-title":"Blood"},{"issue":"07","key":"ref29","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/1076029616670257","article-title":"Factor VII deficiency: from basics to clinical laboratory diagnosis and patient management","volume":"23","author":"P O Sevenet","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"issue":"03","key":"ref30","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1182\/blood.V81.3.734.734","article-title":"Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation","volume":"81","author":"J H Morrissey","year":"1993","journal-title":"Blood"},{"issue":"01","key":"ref31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2516.2001.00478.x","article-title":"A comparison of FVII:C and FVIIa assays for the monitoring of recombinant factor VIIa treatment","volume":"7","author":"A R Cid","year":"2001","journal-title":"Haemophilia"},{"issue":"05","key":"ref32","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3324\/haematol.2011.049403","article-title":"Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency","volume":"97","author":"A Branchini","year":"2012","journal-title":"Haematologica"},{"issue":"05","key":"ref33","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/hae.12160","article-title":"Use of global assays to understand clinical phenotype in congenital factor VII deficiency","volume":"19","author":"L A Greene","year":"2013","journal-title":"Haemophilia"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/hae.12256","article-title":"Use of thromboelastography and thrombin generation assay to predict clinical phenotype in patients with severe FVII deficiency","volume":"20","author":"H T Tran","year":"2014","journal-title":"Haemophilia"},{"issue":"8621","key":"ref35","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(88)90259-0","article-title":"Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy","volume":"2","author":"U Hedner","year":"1988","journal-title":"Lancet"},{"issue":"02","key":"ref36","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1160\/TH13-12-1045","article-title":"Pharmacokinetic properties of recombinant FVIIa in inherited FVII deficiency account for a large volume of distribution at steady state and a prolonged pharmacodynamic effect","volume":"112","author":"M Morfini","year":"2014","journal-title":"Thromb Haemost"},{"issue":"20","key":"ref37","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1182\/blood-2014-05-576892","article-title":"In vitro evidence of a tissue factor-independent mode of action of recombinant factor VIIa in hemophilia","volume":"124","author":"C Augustsson","year":"2014","journal-title":"Blood"},{"issue":"04","key":"ref38","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3324\/haematol.2012.074039","article-title":"Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER)","volume":"98","author":"M Napolitano","year":"2013","journal-title":"Haematologica"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.thromres.2019.07.014","article-title":"The use of prophylaxis in the treatment of rare bleeding disorders","volume":"196","author":"A Shapiro","year":"2020","journal-title":"Thromb Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bcmd.2016.12.008","article-title":"Primary prophylaxis for children with severe congenital factor VII deficiency - clinical and laboratory assessment","volume":"67","author":"A A Kuperman","year":"2017","journal-title":"Blood Cells Mol Dis"},{"issue":"03","key":"ref41","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1055\/s-0038-1646742","article-title":"Treatment of congenital factor VII deficiency with a new concentrate","volume":"39","author":"G Mariani","year":"1978","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref42","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1046\/j.1538-7836.2003.00395.x","article-title":"Thrombosis in inherited factor VII deficiency","volume":"1","author":"G Mariani","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"S 01","key":"ref43","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.thromres.2012.08.273","article-title":"Is the coexistence of thromboembolic events and Factor VII deficiency fortuitous?","volume":"130","author":"M Giansily-Blaizot","year":"2012","journal-title":"Thromb Res"},{"issue":"03","key":"ref44","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1365-2516.2007.01647.x","article-title":"The paradoxical association between inherited factor VII deficiency and venous thrombosis","volume":"14","author":"S Marty","year":"2008","journal-title":"Haemophilia"},{"key":"ref45","first-page":"2023","volume-title":"Inhibitors in hemophilias","author":"G Mariani","year":"2018"},{"issue":"02","key":"ref46","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/jcm10020211","article-title":"Inhibitor in congenital factor VII deficiency; a rare but serious therapeutic challenge-a systematic literature review","volume":"10","author":"N Ramezanpour","year":"2021","journal-title":"J Clin Med"},{"issue":"05","key":"ref47","first-page":"972","article-title":"Coagulation factor VII variants resistant to inhibitory antibodies","volume":"112","author":"A Branchini","year":"2014","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref48","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1073\/pnas.70.2.310","article-title":"Activation of a proteolytic system by a membrane lipoprotein: mechanism of action of tissue factor","volume":"70","author":"Y Nemerson","year":"1973","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"07","key":"ref49","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1055\/s-0035-1564044","article-title":"Structure function relationship of the interaction between tissue factor and factor VIIa","volume":"41","author":"J M Gajsiewicz","year":"2015","journal-title":"Semin Thromb Hemost"},{"issue":"6569","key":"ref50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/380041a0","article-title":"The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor","volume":"380","author":"D W Banner","year":"1996","journal-title":"Nature"},{"issue":"15","key":"ref51","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1073\/pnas.84.15.5158","article-title":"Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation","volume":"84","author":"P J O'Hara","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"03","key":"ref52","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/hae.12604","article-title":"Congenital combined deficiency of coagulation factors VII and X\u2013different genetic mechanisms","volume":"21","author":"A Pavlova","year":"2015","journal-title":"Haemophilia"},{"issue":"7993","key":"ref53","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","article-title":"A genomic mutational constraint map using variation in 76,156 human genomes","volume":"625","author":"S Chen","year":"2024","journal-title":"Nature"},{"issue":"08","key":"ref54","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1073\/pnas.83.8.2412","article-title":"Characterization of a cDNA coding for human factor VII","volume":"83","author":"F S Hagen","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"03","key":"ref55","first-page":"387","article-title":"Factor VII Padua: a congenital coagulation disorder due to an abnormal factor VII with a peculiar activation pattern","volume":"91","author":"A Girolami","year":"1978","journal-title":"J Lab Clin Med"},{"issue":"07","key":"ref56","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/humu.24025","article-title":"The EAHAD blood coagulation factor VII variant database","volume":"41","author":"M Giansily-Blaizot","year":"2020","journal-title":"Hum Mutat"},{"issue":"03","key":"ref57","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3324\/haematol.2019.217539","article-title":"Next-generation sequencing and recombinant expression characterized aberrant splicing mechanisms and provided correction strategies in factor VII deficiency","volume":"105","author":"P Ferraresi","year":"2020","journal-title":"Haematologica"},{"issue":"01","key":"ref58","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/hae.13638","article-title":"Whole exome sequencing in the diagnostic workup of patients with a bleeding diathesis","volume":"25","author":"J L Saes","year":"2019","journal-title":"Haemophilia"},{"issue":"04","key":"ref59","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/ana.26033","article-title":"Monogenic causes of apparently idiopathic perinatal intracranial hemorrhage","volume":"89","author":"M Hausman-Kedem","year":"2021","journal-title":"Ann Neurol"},{"issue":"01","key":"ref60","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1182\/blood.V89.1.176","article-title":"Severe factor VII deficiency due to a mutation disrupting a hepatocyte nuclear factor 4 binding site in the factor VII promoter","volume":"89","author":"A A Arbini","year":"1997","journal-title":"Blood"},{"issue":"02","key":"ref61","first-page":"277","article-title":"Lethal factor VII deficiency due to novel mutations in the F7 promoter: functional analysis reveals disruption of HNF4 binding site","volume":"108","author":"M Giansily-Blaizot","year":"2012","journal-title":"Thromb Haemost"},{"issue":"05","key":"ref62","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/BF00217463","article-title":"A polymorphism in the 5\u2032 region of coagulation factor VII gene (F7) caused by an inserted decanucleotide","volume":"90","author":"G Marchetti","year":"1993","journal-title":"Hum Genet"},{"issue":"10","key":"ref63","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1182\/blood.V93.10.3432.410k16_3432_3441","article-title":"Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration","volume":"93","author":"F M van 't Hooft","year":"1999","journal-title":"Blood"},{"issue":"03","key":"ref64","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/01.ATV.11.3.540","article-title":"A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals","volume":"11","author":"F Green","year":"1991","journal-title":"Arterioscler Thromb"},{"issue":"01","key":"ref65","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/ATVB.16v01.0072","article-title":"Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma","volume":"16","author":"F Bernardi","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"05","key":"ref66","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/BF00216448","article-title":"Molecular analysis of factor VII deficiency in Italy: a frequent mutation (FVII Lazio) in a repeated intronic region","volume":"92","author":"F Bernardi","year":"1993","journal-title":"Hum Genet"},{"issue":"05","key":"ref67","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood.V92.5.1646.417k16_1646_1651","article-title":"Molecular mechanisms of FVII deficiency: expression of mutations clustered in the IVS7 donor splice site of factor VII gene","volume":"92","author":"M Pinotti","year":"1998","journal-title":"Blood"},{"issue":"14","key":"ref68","first-page":"8516","article-title":"Coagulation factor VII Gln100 \u2013> Arg. Amino acid substitution at the epidermal growth factor 2-protease domain interface results in severely reduced tissue factor binding and procoagulant function","volume":"273","author":"G Kemball-Cook","year":"1998","journal-title":"J Biol Chem"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1042\/bj3630411","article-title":"A frequent human coagulation factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates","volume":"363","author":"R Toso","year":"2002","journal-title":"Biochem J"},{"issue":"09","key":"ref70","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.3390\/genes14091767","article-title":"Molecular genetic analysis of Russian patients with coagulation factor FVII deficiency","volume":"14","author":"O Pshenichnikova","year":"2023","journal-title":"Genes (Basel)"},{"issue":"12","key":"ref71","first-page":"1434","article-title":"The Gly331Ser mutation in factor VII in Europe and the Middle East","volume":"88","author":"D Etro","year":"2003","journal-title":"Haematologica"},{"issue":"03","key":"ref72","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/bjh.18768","article-title":"Structural and functional characterization of novel F7 mutations identified in Chinese factor VII-deficient patients","volume":"202","author":"C Lou","year":"2023","journal-title":"Br J Haematol"},{"issue":"02","key":"ref73","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/hae.14730","article-title":"Molecular spectrum of inherited FVII deficiency in North India revealed a recurrent variant with a founder effect","volume":"29","author":"R Sharma","year":"2023","journal-title":"Haemophilia"},{"issue":"01","key":"ref74","doi-asserted-by":"crossref","first-page":"100003","DOI":"10.1016\/j.rpth.2022.100003","article-title":"Extensive genetic screening of Iranian Factor FVII-deficient individuals unraveled several novel mutations and postulated founder effects in some cases","volume":"7","author":"S Ravanbod","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"03","key":"ref75","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1365-2141.1994.tb04793.x","article-title":"Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII","volume":"86","author":"F Bernardi","year":"1994","journal-title":"Br J Haematol"},{"issue":"03","key":"ref76","first-page":"493","article-title":"Generation of genetically-altered mice producing very low levels of coagulation factor VII","volume":"94","author":"E D Rosen","year":"2005","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref77","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1111\/jth.13443","article-title":"Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency","volume":"14","author":"A Branchini","year":"2016","journal-title":"J Thromb Haemost"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2119\/2005-00040.Rizzotto","article-title":"Intracellular evaluation of ER targeting elucidates a mild form of inherited coagulation deficiency","volume":"12","author":"L Rizzotto","year":"2006","journal-title":"Mol Med"},{"issue":"01","key":"ref79","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1182\/blood.V78.1.132.132","article-title":"Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male","volume":"78","author":"D P O'Brien","year":"1991","journal-title":"Blood"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1042\/bj20020888","article-title":"Factor VII mutant V154G models a zymogen-like form of factor VIIa","volume":"369","author":"R Toso","year":"2003","journal-title":"Biochem J"},{"issue":"05","key":"ref81","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1538-7836.2008.02934.x","article-title":"Vitamin K-induced modification of coagulation phenotype in VKORC1 homozygous deficiency","volume":"6","author":"G Marchetti","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref82","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1074\/jbc.RA119.009183","article-title":"Beating tissue factor at its own game: design and properties of a soluble tissue factor-independent coagulation factor VIIa","volume":"295","author":"A B Sorensen","year":"2020","journal-title":"J Biol Chem"},{"issue":"01","key":"ref83","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/16078454.2019.1700329","article-title":"Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency","volume":"25","author":"B L Gorkom","year":"2020","journal-title":"Hematology"},{"issue":"565","key":"ref84","doi-asserted-by":"crossref","first-page":"eabb0580","DOI":"10.1126\/scitranslmed.abb0580","article-title":"An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics","volume":"12","author":"M Bern","year":"2020","journal-title":"Sci Transl Med"},{"issue":"06","key":"ref85","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/hae.12994","article-title":"TRUST trial: BAY 86-6150 use in haemophilia with inhibitors and assessment for immunogenicity","volume":"22","author":"J Mahlangu","year":"2016","journal-title":"Haemophilia"},{"issue":"03","key":"ref86","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/cpt.3172","article-title":"Subcutaneous marzeptacog alfa (activated) for on-demand treatment of bleeding events in subjects with hemophilia A or B with inhibitors","volume":"115","author":"A Faraj","year":"2024","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"ref87","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/17474086.2023.2248385","article-title":"Efficacy and safety evaluation of eptacog beta (coagulation factor VIIa [recombinant]-jncw) for the treatment of hemophilia A and B with inhibitors","volume":"16","author":"S W Pipe","year":"2023","journal-title":"Expert Rev Hematol"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s44161-023-00418-4","article-title":"A bispecific antibody approach for the potential prophylactic treatment of inherited bleeding disorders","volume":"3","author":"P S Gandhi","year":"2024","journal-title":"Nat Cardiovasc Res"},{"issue":"05","key":"ref89","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1182\/blood-2015-09-671420","article-title":"Sustained correction of FVII deficiency in dogs using AAV-mediated expression of zymogen FVII","volume":"127","author":"O A Marcos-Contreras","year":"2016","journal-title":"Blood"},{"issue":"08","key":"ref90","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/j.1538-7836.2006.02057.x","article-title":"Gentamicin induces sub-therapeutic levels of coagulation factor VII in patients with nonsense mutations","volume":"4","author":"M Pinotti","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref91","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/jth.12471","article-title":"An engineered U1 small nuclear RNA rescues splicing defective coagulation F7 gene expression in mice","volume":"12","author":"D Balestra","year":"2014","journal-title":"J Thromb Haemost"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13578-019-0333-8","article-title":"The effect of the chemical chaperone 4-phenylbutyrate on secretion and activity of the p.Q160R missense variant of coagulation factor FVII","volume":"9","author":"E Andersen","year":"2019","journal-title":"Cell Biosci"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"28304","DOI":"10.1038\/srep28304","article-title":"An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes","volume":"6","author":"E Barbon","year":"2016","journal-title":"Sci Rep"},{"issue":"13","key":"ref94","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.3390\/app11135762","article-title":"The factor VII variant p.A354V-p.P464Hfs: clinical versus intracellular and biochemical phenotypes induced by chemical chaperones","volume":"11","author":"E Andersen","year":"2021","journal-title":"Appl Sci (Basel)"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1788792.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:41:58Z","timestamp":1740008518000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1788792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":93,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2025,2,19]]},"published-print":{"date-parts":[[2025,3]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1788792","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,29]]}}}